Moneycontrol PRO

Instant Loan Offers

you are here: HomeNewsBusinessEarningsDishman Pharma sees Rs 100 cr debt reduction in FY16

SHOW NAMES

Trending Topics

business

Dishman Pharma sees Rs 100 cr debt reduction in FY16

Talking on their SEZ sale plans he said they would wait for the Budget before deciding on it, said Arpit Vyas, MD, Dishman Pharma.

first published: Feb 16, 2015 01:12 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Nifty Sideways But Holds 26,000 Ahead Of MPC Rate Decision| IT & Realty Upbeat| Closing Bell Live
Live: RBI Policy Expectations| Rupee Slide, Strong GDP & Soft Inflation – Will MPC Cut Or Pause?
Nifty Holds Key Support; Volatile Trade Likely on Sensex Expiry | Opening Bell Live
Rupee Slide Weighs Heavy As Nifty Tests 25,900| Midcaps See Sharp Cuts| Closing Bell Live

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347